Loading ETF research
Fetching the latest fund profile, holdings, and market data.
Fetching the latest fund profile, holdings, and market data.
New York Stock Exchange Arca · Sector Equity
$107.47
+$0.70 · +0.66%
· Aug 21, 4:00 PM ET
$107.47
Previous close+$0.70 · +0.66%
· Aug 21, 4:00 PM ET
$107.46
+$0.69 · +0.65%
Regular session · ET · Market data may be delayed.
The Virtus Biotech ETF seeks to replicate the overall financial performance, encompassing both price appreciation and income generation, of the LifeSci Biotechnology Products Index, prior to any deductions for fees and expenses. This index specifically comprises biotechnology companies that have received approval from the FDA for at least one drug therapy. Furthermore, the fund underwent a name change on February 27, transitioning from Virtus LifeSci Biotech Products ETF to its current designation.
Fund assets
111.81M USD
Expense ratio
0.34%
NAV
$106.49
Average volume
9.7K
Volume
12.05K
Day range
$106.92 – $108.76
52-week range
$66.55 – $109.95
Previous close
$106.77
Price change
1 day
+0.66%
1 month
+10.50%
3 months
+24.81%
Year to date
+34.49%
1 year
+61.27%
3 years
+103.54%
5 years
+109.29%
Price changes exclude distributions, fees, taxes, and investor-specific cash flows.
Portfolio
Holdings data updated Aug 23, 2026.
Portfolio composition
Fund income
Dec 20, 2017
Annual
Dec 21, 2017
Dec 27, 2017
$0.0723
Dec 21, 2015
Annual
Dec 23, 2015
Dec 29, 2015
$0.397
Latest coverage
More funds
Continue in GoAI
Connect this ETF with broader market context and continue your research in GoAI.
ETF data may be delayed, incomplete, or revised. Holdings and exposures change over time. Historical performance does not guarantee future results. This page is for informational and educational purposes only and does not constitute investment advice or a recommendation.
